当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
orforglipron
DRUG FOR FURTHER PROCESSING
0110-1230
Lilly del Caribe, Inc.
20251122
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
12
0110-1230_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
orforglipron
DRUG FOR FURTHER PROCESSING
0110-1520
Lilly del Caribe, Inc.
20251112
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
24
0110-1520_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
orforglipron
DRUG FOR FURTHER PROCESSING
0110-1625
Lilly del Caribe, Inc.
20251104
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
36
0110-1625_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
selpercatinib
DRUG FOR FURTHER PROCESSING
0110-2980
Eli Lilly and Company
20210401
SELPERCATINIB
DRUG FOR FURTHER PROCESSING
80
0110-2980_b49bf006-0bfb-440c-9838-fadc022de275
Fluoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3104
Lilly del Caribe, Inc.
20150101
FLUOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10
0110-3104_cdf70bb1-3252-4bf5-80b9-f40268bc1e03
Fluoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3105
Lilly del Caribe, Inc.
20150101
FLUOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0110-3105_cdf70bb1-3252-4bf5-80b9-f40268bc1e03
Fluoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3107
Lilly del Caribe, Inc.
20150101
FLUOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
40
0110-3107_cdf70bb1-3252-4bf5-80b9-f40268bc1e03
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3227
Lilly del Caribe, Inc.
20021126
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10
0110-3227_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3228
Lilly del Caribe, Inc.
20021126
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
25
0110-3228_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3229
Lilly del Caribe, Inc.
20021126
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
40
0110-3229_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3235
Lilly del Caribe, Inc.
20040824
DULOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0110-3235_a2802fac-1267-445b-8e16-3a4204b8acec
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3238
Lilly del Caribe, Inc.
20021126
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
18
0110-3238_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3239
Lilly del Caribe, Inc.
20021126
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
60
0110-3239_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3240
Lilly del Caribe, Inc.
20040824
DULOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
30
0110-3240_a2802fac-1267-445b-8e16-3a4204b8acec
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3250
Lilly del Caribe, Inc.
20050214
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
80
0110-3250_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Atomoxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3251
Lilly del Caribe, Inc.
20050214
ATOMOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
100
0110-3251_b2cbf823-34b4-4e9b-800d-f094d61c6ba4
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-3270
Lilly del Caribe, Inc.
20100115
DULOXETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
60
0110-3270_a2802fac-1267-445b-8e16-3a4204b8acec
selpercatinib
DRUG FOR FURTHER PROCESSING
0110-3977
Eli Lilly and Company
20210401
SELPERCATINIB
DRUG FOR FURTHER PROCESSING
40
0110-3977_b49bf006-0bfb-440c-9838-fadc022de275
orforglipron
DRUG FOR FURTHER PROCESSING
0110-4178
Lilly del Caribe, Inc.
20251002
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
.8
0110-4178_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
baricitinib
DRUG FOR FURTHER PROCESSING
0110-4182
Lilly del Caribe, Inc.
20170116
BARICITINIB
DRUG FOR FURTHER PROCESSING
2
0110-4182_8564dd56-b161-4792-b9b0-95aefbab9742
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3